Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions

Xuejun Fan and Zihao Yuan and Yueshui Zhao and Wei Xiong and Hsiao, Hao-Ching and Rahmawati Pare and Jianmin Ding and Ahmad Almosa and Kai Sun and Songlin Zhang and Jordan, Robert E. and Cheok, Song Lee and Zhiqiang An and Ningyan Zhang (2022) Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions. Communications Biology, 5. pp. 1-14. ISSN 2399-3642

[img] Text
FULL TEXT.pdf
Restricted to Registered users only
Download (612kB) | Request a copy
[img] Text
ABSTRACT.pdf
Download (86kB)

Abstract

Natural killer (NK) cells mediate antibody dependent cytotoxic killing of cancer cells via cross-linking FcγR on NK cells with IgG-Fc. Studies have shown that the single-hinge cleaved IgGs (scIgGs) have dysfunctional Fc and failed engagement with FcγRs on immune cells. However, little is known about how scIgGs impact on antitumor immunity in the tumor microenvironment. In this study, we revealed a significant association of tumor scIgGs with tumor progression and poor outcomes of breast cancer patients (n = 547). Using multiple mouse tumor models, we demonstrated that tumor scIgGs reduced NK cell cytotoxic activities and resulted in aggressive tumor progression. We further showed that an anti-hinge specific monoclonal antibody (AHA) rescued the dysfunctional Fc in scIgGs by providing a functional Fc and restored NK cell cytotoxic activity. These findings point to a novel immunotherapeutic strategy to enhance Fc engagement with FcγRs for activation of anticancer immunity.

Item Type: Article
Keyword: Natural killer , NK , Antitumor
Subjects: R Medicine > RC Internal medicine > RC31-1245 Internal medicine > RC254-282 Neoplasms. Tumors. Oncology Including cancer and carcinogens
Department: FACULTY > Faculty of Medicine and Health Sciences
Depositing User: SAFRUDIN BIN DARUN -
Date Deposited: 31 Oct 2022 09:23
Last Modified: 31 Oct 2022 09:23
URI: https://eprints.ums.edu.my/id/eprint/34647

Actions (login required)

View Item View Item